+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Diagnostics - Global Market Trajectory & Analytics

  • ID: 338882
  • Report
  • September 2020
  • Region: Global
  • 609 Pages
  • Global Industry Analysts, Inc
Diabetes is the Largest Epidemic in Human History Surpassing Even the Black Death of the 14th Century. Diabetes Diagnostics to Reach a Colossal $45.6Billion

The global market for Diabetes Diagnostics is projected to reach US$45.6billion by the year 2027, trailing a post COVID-19 CAGR of 8.1% over the analysis period 2020 through 2027. Wiping out over 20% of the world's population in the 14th century, Black Death was the most devastating pandemics in human history. Today type 2 diabetes is gradually emerging into an epidemic much bigger than Black Death. The disease will continue to grow driven by the growing incidence of diabetes in parallel to obesity and the ensuing rise of diabesity as a global epidemic; improper lifestyle patterns and the resulting increase in risk factors even among non-obese population. The diagnosis and treatment of diabetes have always been challenging for both the healthcare providers and the patients. Keeping up with regular exercises, diabetic meal plans, medications, and check on blood sugar levels are never easy. Diabetic patients need continuous self-management on a regular basis. It is also a tedious task for the doctors to analyze blood sugar fluctuations and other factors involved in diabetes care. Further in developing economies, managing diabetes and the complications associated with it is a big challenge due to issues such as lack of healthcare professionals, limited access to healthcare facilities, lack of awareness among people and lack of information that enables therapeutic decision-making.

All these problems contribute to missed diagnosis and delayed visits to the clinics. However, technological advancements are anticipated to solve these problems to a great extent. Advancements in the food and information technologies have revolutionized the diagnosis and treatment of diabetes. Amid the ongoing COVID-19 situation, technology seems to be provided with a chance to prove its worth more than ever before. With the latest technologies in healthcare sector such as food trackers, health apps, glucometers and pedometers, tracking of data has become easy to manage. Technology is expected to bring latest developments particularly during the COVID-19 times, where social distancing is the new norm. Introduction of glucometers, EMRs, mobile apps and digital clinics has made data tracking and lifestyle change much easier. Other technologies such as social media educate and motivate the diabetic patients to bring a change in their lifestyle. The market especially stands to benefit from the rapid advances being made in the field of continuous glucose monitoring such as smart predictive algorithms for automated control; growing understanding of diabetes pathophysiology and the resulting development of more potent disease prevention, control and management strategies; focus on diabetes self-management and research interest in the development of diabetes tracking wearable devices; growing revenue opportunity for mHealth solutions for diabetes diagnosis; launch of implantable continuous glucose monitor and cloud-enabled CGM devices; rising popularity of near patient testing and the resulting demand for HbA1c devices and encouraging research breakthroughs in artificial pancreas.

Another worrisome trend positively influencing growth in the market is the increasing incidence of diabetes in children and the resulting focus on shed on timely screening, diagnosis and therapy administration among pediatric patients. Mainstream adoption universal screening for gestational diabetes mellitus (GDM) will also drive revenue opportunities in the market. Asia-Pacific ranks as the fastest growing market led by grim risk population analysis attributable to rapid urbanization, growing affluence and nutrition transition, less physically demanding lifestyles, high prevalence of smoking, alcohol abuse, heavy consumption of refined carbohydrates, lack of exercise and over nutrition. India and China represent the epicenter of the diabetes epidemic with both the countries recording the highest number of diabetics in the region. For long, genes, lifestyle & behavioral change have been in the spotlight as risk factors for developing type 2 diabetes. Currently, epigenetic changes are emerging to be forefront as a possible reason for the rising incidence of type 2 diabetes. While treatment regimes are evolving, routine testing has and will continue to remain vital in effective diabetes management. There is an acute need for easy-to-use, efficient, accurate and affordable solutions for effective management of the disease; and technology innovation and development of non-invasive techniques to simplify regular glucose testing. The most popular home diagnostic device is the blood glucose monitor that assists in detecting the amount of glucose present in blood. A special coated strip containing blood sample is inserted into the machine, which consequently yields results on a digital display. Certain blood glucose monitors are also equipped with a memory component capable of holding multiple test results. Analog glucose monitors are traditional blood glucose meters that uses a blood sample drawn from pricking a patient's finger.

Competitors identified in this market include, among others:
  • A.Menarini Diagnostics Ltd.
  • Abbott Diabetes Care Inc.
  • Acon Laboratories Inc.
  • AgaMatrix Inc.
  • Apex Biotechnology Corporation
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • BIONIME Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DexCom Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • HemoCue® AB
  • LifeScan, Inc.
  • Medtronic PLC
  • Nova Biomedical Corporation
  • OSANG Healthcare Co. Ltd.
  • PTS Diagnostics
  • Sanofi S.A.
  • Sanwa Kagaku Kenkyusho Co Ltd.
  • Siemens Healthineers
  • Sinocare Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Tosoh Bioscience Inc.
  • Trinity Biotech plc
  • Trividia Health Inc.
  • Ypsomed AG

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of COVID-19 and a Looming Global Recession
  • Technologies Come to the Aid for Diabetes Diagnosis, Monitoring and Management
  • Diabetes: A Chronic Body Disorder
  • An Introduction to Diabetes Diagnostics
  • Diabetes Diagnostics: Easier, Economic, and Efficient Management of the Global Diabetes Epidemic
  • Developed Regions Lead, Developing Economies to Spearhead Future Growth
  • Increase in Number of Hospitals & Diagnostics Centers Augurs Well for Market in Developing Regions
  • Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Diabetes Diagnostic Devices
  • EXHIBIT 1: World Diabetes and Population Statistics (2019, 2030 & 2045)
  • EXHIBIT 2: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
  • EXHIBIT 3: World Diabetes Prevalence (2000-2019)
  • EXHIBIT 4: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2019 and 2045
  • EXHIBIT 5: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
  • Diabetes Emerges as One of the Leading Causes of Mortality
  • EXHIBIT 6: Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
  • Competition
  • EXHIBIT 7: Global Continuous Glucose Monitoring Market Breakdown (in %) by Leading Competitors for 2019
  • EXHIBIT 8: Global Blood Glucose Monitoring Devices Market Share (in %) by Company for 2019
  • Quality Products at Low Prices: Mantra for Success in the Marketplace
  • SMBG Makers Turn to Mobile Devices to Woo Users on the Move
  • World Brands
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • High Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
  • EXHIBIT 9: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • EXHIBIT 10: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
  • EXHIBIT 11: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
  • EXHIBIT 12: Diabetes-Related Health Expenditure: Average Spending Per Person (in US$) by Region for 2010 and 2019
  • Increasing Obesity Levels Underpins Market Growth
  • EXHIBIT 13: Average Per Capita Annual Health Expenditure (In US$) due to Obesity
  • EXHIBIT 14: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Rising Importance of Real-Time Glucose Sensing and Monitoring Drive Robust Growth in Minimally-Invasive CGM Devices Market
  • EXHIBIT 15: Global Continuous Glucose Monitoring Systems Market by Component for 2020E
  • EXHIBIT 16: Global Continuous Glucose Monitoring Systems Market by End-Use (in %) for 2020E
  • CGM Demand Benefits from the COVID-19 Pandemic
  • CGM Market Breaks through Barriers to Witness Growing Adoption
  • Growing Role of HbA1c Testing Devices in Monitoring & Management of Diabetes
  • Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
  • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
  • Glycated Albumin: A Potential Threat to HbA1c
  • Role of HbA1c Testing in Diabetes Diagnosis and Management
  • HbA1c Tests for Diabetes Diagnosis Need to Address Issues Related to Hemoglobin Variants
  • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
  • Despite Competition from CGM Systems and HbA1c Testing Devices, BGM Devices Continues to Witness Demand Growth
  • Blood Glucose Strips: Low Cost Advantage Augurs Drives Market
  • Blood Sugar Lancets Market: Sustained Growth in Demand
  • Self-Monitoring/Household Blood Glucose Sustains Market Growth
  • Rising Smartphone Penetration Augurs Well for SMBG Market
  • EXHIBIT 17: Smartphone Penetration Rate as Share of Total Population: 2016-2020
  • Barriers to Adoption of New Technology in BGM Products
  • Accuracy Issues Plague Blood Glucose Meters Market
  • Insulin Pens Rise in Popularity for Administering Insulin
  • Smart Insulin Pens
  • Increasing Role of Self-Injection Devices in Diabetes Management
  • Prefilled Syringe Pen Injectors
  • Human Factors Influence the Design of Self Injection Systems
  • Pain Free Shots: A Growing R&D Domain
  • Undiagnosed Diabetes Emerges as a Major Healthcare Challenge, Translates into Untapped Potential for Diabetes Diagnostics Market
  • EXHIBIT 18: Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
  • EXHIBIT 19: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
  • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Diagnostic Devices
  • Innovations & Product Advancements: Prime Focus Area for Vendors
  • Focus on Development of Wearable Devices
  • An Insight into Intriguing Advances in Blood Glucose Monitoring Techniques
  • Companies Develop Innovative Needle-Free Alternatives
  • mHealth Solutions for Diabetes Diagnosis
  • Non-invasive Wearable Glucose Testing Devices
  • Innovations in Insulin Pumps
4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS
  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
  • With Diabetes Emerging as a Major Lifestyle Disease, Diabetes Diagnostics Market Poised for Growth in the US
  • EXHIBIT 20: Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045)
  • EXHIBIT 21: Diabetes Prevalence by Ethnicity: 2019
  • Aging Demographics: A Factor Driving Diabetes Prevalence
  • EXHIBIT 22: Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030
  • EXHIBIT 23: North American Aging Population (in Thousands) by Age Group: 1975-2050
  • EXHIBIT 24: Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019
  • Rising Significance of Wearable and Non-Invasive Glucose Monitoring Devices
  • Regulatory Guidance for Glucose Meter Companies
  • Insulin Syringes Dominate the Insulin Delivery Devices Market
  • Emerging Grey Market for Testing Strips
  • Competition
  • Companies Focus on Research for Better Diabetes Diagnostics
  • Market Analytics
  • CANADA
  • Rising Diabetes Incidence in Canada: Opportunity for Diabetes Diagnostics Market
  • EXHIBIT 25: Diabetes Statistics in Canada (2019): Number of Adults with Diabetes (20-79) (in 000s), Diabetes National Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)
  • Market Analytics
  • JAPAN
  • Aging Population Drives Diabetes Diagnostics Market
  • EXHIBIT 26: Diabetes Statistics in Japan (2019): Number of Adults with Diabetes (in ‘000s), Adults with Undiagnosed Diabetes (in ‘000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), and Number of Diabetes-Related Deaths (in ‘000s)
  • Market Analytics
  • CHINA
  • Increasing Diabetes Incidence Drives Market Growth
  • EXHIBIT 27: Diabetes Statistics in China for 2019
  • Lower Penetration Offers High Growth Potential
  • EXHIBIT 28: Chinese Glucose Meters Breakdown of Revenues by Leading Companies for 2019
  • Market Analytics
  • EUROPE
  • Diabetes Diagnostics Market in Europe: A Promising Outlook
  • EXHIBIT 29: Diabetes and Population Statistics in Europe (2019, 2030 & 2045)
  • EXHIBIT 30: Diabetes Statistics in Europe (2019): Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries
  • Reimbursement Scenario
  • Market Analytics
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • Asia-Pacific: Rising Diabetes Incidence Offers Significant Growth Opportunities
  • EXHIBIT 31: Diabetes and Population Statistics in South East Asia (2019 & 2045)
  • EXHIBIT 32: Diabetes and Population Statistics in Western Pacific (2019 & 2045)
  • EXHIBIT 33: Diabetes Statistics in Select Asia-Pacific Countries: Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for 2019
  • Public and Private Sector Diabetes Care
  • Market Analytics
  • AUSTRALIA
  • INDIA
  • Expanding Diabetic Population Spurs Growth in the Indian Market
  • Blood Glucose Monitoring Market: An Overview
  • HbA1c Testing Continues to Gain Momentum
  • Glucose Meters Rely on Imported Technology
  • Market Analytics
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Rising Diabetes Cases Present Opportunities for Diabetes Diagnostics in Latin America
  • EXHIBIT 34: Diabetes and Population Statistics in South & Central America (2019 & 2045)
  • Market Analytics
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
IV. COMPETITION
  • Total Companies Profiled: 91
Note: Product cover images may vary from those shown
Adroll
adroll